Catalyst Wire Dossier Catalyst Wire Dossier

Chiron Meningococcal C Conjugate Vaccine

Meningococcal C conjugate vaccine · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Chiron Meningococcal C Conjugate Vaccine, covering 2007-03-13 to 2007-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age [Phase 3]

See pricing